Mimivax Inc.
Pharmaceutical company · Buffalo, New York, United States
Mimivax Inc. is a pharmaceutical company headquartered in Buffalo, New York, United States. Its earliest recorded incorporation is in 2011. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $463,979 in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $5.8 million sold in a notice filed in 2024.
What does Mimivax do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $463,979 in total (2022). NIH funding came from the National Institute of Neurological Disorders and Stroke.
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $5.8 million sold (2024).
Frequently asked questions about Mimivax
Where is Mimivax headquartered?
Mimivax Inc. is headquartered in Buffalo, New York, United States.
What does Mimivax do?
Mimivax Inc. is a pharmaceutical company.
When was Mimivax founded?
The earliest incorporation on record for Mimivax Inc. is in 2011, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.